STOCK TITAN

Natural Health Trends Reports Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Natural Health Trends Corp. (NHTC) reported its Q4 and full-year 2024 financial results. Q4 revenue remained stable at $10.8 million compared to $10.9 million in Q4 2023, with Hong Kong business showing a 9% sequential increase and 7% year-over-year growth. The company reported a Q4 operating loss of $421,000 and net income of $176,000 ($0.02 per diluted share).

For full-year 2024, revenue decreased 2% to $43.0 million, with an operating loss of $1.3 million and net income of $572,000 ($0.05 per diluted share). Active Members stood at 30,870 as of December 31, 2024, showing a 5% decrease from the previous year. The company maintained positive cash flows from operations before 2017 Tax Act installment and declared a quarterly cash dividend of $0.20 per share. Total cash and equivalents were $43.9 million as of December 31, 2024.

Natural Health Trends Corp. (NHTC) ha riportato i risultati finanziari per il quarto trimestre e l'intero anno 2024. I ricavi del quarto trimestre sono rimasti stabili a 10,8 milioni di dollari rispetto ai 10,9 milioni di dollari del quarto trimestre 2023, con il business di Hong Kong che ha mostrato un aumento sequenziale del 9% e una crescita anno su anno del 7%. L'azienda ha registrato una perdita operativa di 421.000 dollari nel quarto trimestre e un utile netto di 176.000 dollari (0,02 dollari per azione diluita).

Per l'intero anno 2024, i ricavi sono diminuiti del 2% a 43,0 milioni di dollari, con una perdita operativa di 1,3 milioni di dollari e un utile netto di 572.000 dollari (0,05 dollari per azione diluita). I membri attivi erano 30.870 al 31 dicembre 2024, mostrando una diminuzione del 5% rispetto all'anno precedente. L'azienda ha mantenuto flussi di cassa positivi dalle operazioni prima dell'installamento della legge fiscale del 2017 e ha dichiarato un dividendo in contante trimestrale di 0,20 dollari per azione. La liquidità totale e le equivalenti erano di 43,9 milioni di dollari al 31 dicembre 2024.

Natural Health Trends Corp. (NHTC) informó sobre sus resultados financieros del cuarto trimestre y del año completo 2024. Los ingresos del cuarto trimestre se mantuvieron estables en 10,8 millones de dólares en comparación con 10,9 millones de dólares en el cuarto trimestre de 2023, con el negocio de Hong Kong mostrando un aumento secuencial del 9% y un crecimiento interanual del 7%. La empresa reportó una pérdida operativa de 421,000 dólares en el cuarto trimestre y una ganancia neta de 176,000 dólares (0,02 dólares por acción diluida).

Para el año completo 2024, los ingresos disminuyeron un 2% a 43,0 millones de dólares, con una pérdida operativa de 1,3 millones de dólares y una ganancia neta de 572,000 dólares (0,05 dólares por acción diluida). Los miembros activos eran 30,870 al 31 de diciembre de 2024, lo que representa una disminución del 5% con respecto al año anterior. La empresa mantuvo flujos de efectivo positivos de las operaciones antes de la instalación de la Ley Fiscal de 2017 y declaró un dividendo en efectivo trimestral de 0,20 dólares por acción. El total de efectivo y equivalentes era de 43,9 millones de dólares al 31 de diciembre de 2024.

Natural Health Trends Corp. (NHTC)는 2024년 4분기 및 연간 재무 결과를 보고했습니다. 4분기 수익은 2023년 4분기의 1,090만 달러와 비교하여 1,080만 달러로 안정적으로 유지되었으며, 홍콩 사업은 전분기 대비 9%, 전년 대비 7%의 성장을 보였습니다. 회사는 4분기에 421,000달러의 운영 손실과 176,000달러(희석 기준 주당 0.02달러)의 순이익을 보고했습니다.

2024년 전체 연간 수익은 2% 감소하여 4,300만 달러가 되었으며, 운영 손실은 130만 달러, 순이익은 572,000달러(희석 기준 주당 0.05달러)였습니다. 2024년 12월 31일 기준 활성 회원 수는 30,870명으로, 전년 대비 5% 감소했습니다. 회사는 2017년 세금 법 시행 이전에 운영으로부터 긍정적인 현금 흐름을 유지하며, 주당 0.20달러의 분기 현금 배당금을 선언했습니다. 2024년 12월 31일 기준 총 현금 및 현금성 자산은 4,390만 달러였습니다.

Natural Health Trends Corp. (NHTC) a publié ses résultats financiers pour le quatrième trimestre et l'année entière 2024. Les revenus du quatrième trimestre sont restés stables à 10,8 millions de dollars par rapport à 10,9 millions de dollars au quatrième trimestre 2023, avec une augmentation séquentielle de 9% et une croissance annuelle de 7% pour l'activité à Hong Kong. L'entreprise a déclaré une perte opérationnelle de 421 000 dollars pour le quatrième trimestre et un bénéfice net de 176 000 dollars (0,02 dollar par action diluée).

Pour l'année entière 2024, les revenus ont diminué de 2% à 43,0 millions de dollars, avec une perte opérationnelle de 1,3 million de dollars et un bénéfice net de 572 000 dollars (0,05 dollar par action diluée). Les membres actifs s'élevaient à 30 870 au 31 décembre 2024, avec une baisse de 5% par rapport à l'année précédente. L'entreprise a maintenu des flux de trésorerie positifs provenant des opérations avant la mise en œuvre de la loi fiscale de 2017 et a déclaré un dividende en espèces trimestriel de 0,20 dollar par action. Le total des liquidités et équivalents s'élevait à 43,9 millions de dollars au 31 décembre 2024.

Natural Health Trends Corp. (NHTC) hat die Finanzzahlen für das vierte Quartal und das gesamte Jahr 2024 vorgelegt. Der Umsatz im vierten Quartal blieb mit 10,8 Millionen Dollar stabil im Vergleich zu 10,9 Millionen Dollar im vierten Quartal 2023, wobei das Geschäft in Hongkong ein sequenzielles Wachstum von 9% und ein Jahreswachstum von 7% aufwies. Das Unternehmen berichtete von einem operativen Verlust von 421.000 Dollar im vierten Quartal und einem Nettogewinn von 176.000 Dollar (0,02 Dollar pro verwässerter Aktie).

Für das Gesamtjahr 2024 sank der Umsatz um 2% auf 43,0 Millionen Dollar, mit einem operativen Verlust von 1,3 Millionen Dollar und einem Nettogewinn von 572.000 Dollar (0,05 Dollar pro verwässerter Aktie). Die aktiven Mitglieder beliefen sich zum 31. Dezember 2024 auf 30.870, was einen Rückgang von 5% gegenüber dem Vorjahr darstellt. Das Unternehmen hielt positive Cashflows aus den Betrieben vor der Steuerreform von 2017 aufrecht und erklärte eine vierteljährliche Bar-Dividende von 0,20 Dollar pro Aktie. Insgesamt betrugen die flüssigen Mittel und Zahlungsmitteläquivalente am 31. Dezember 2024 43,9 Millionen Dollar.

Positive
  • Hong Kong business revenue increased 9% sequentially and 7% year-over-year in Q4
  • Positive operating cash flow of $602,000 before tax installment payments in 2024
  • Maintained quarterly dividend of $0.20 per share
  • Strong cash position of $43.9 million
Negative
  • Q4 operating loss increased to $421,000 from $292,000 year-over-year
  • Full-year revenue declined 2% to $43.0 million
  • Operating loss of $1.3 million for full-year 2024
  • Active Members decreased 5% year-over-year
  • Weak performance in Taiwan and North America markets

Insights

Natural Health Trends' Q4 2024 results reveal a complex financial picture that warrants careful analysis. The Hong Kong market's 7% YoY and 9% sequential growth is particularly noteworthy, as it represents a bright spot in an otherwise challenging landscape. This growth in the company's primary market demonstrates resilience despite regional economic headwinds.

The company's financial position shows interesting dynamics: While operating at a loss of $421,000, they've maintained positive cash flow from operations of $602,000 (before Tax Act payments) for 2024, a significant improvement from the $1.2M cash burn in 2023. This operational efficiency gain, combined with a substantial cash position of $43.9M, provides a strong liquidity buffer.

The strategic decision to implement price adjustments and reduce promotions in Taiwan and North America, while potentially impacting short-term sales, demonstrates a prudent focus on margin protection. This approach could strengthen long-term profitability, though it requires careful monitoring of customer retention metrics, as evidenced by the 5% decline in Active Members.

The maintained quarterly dividend of $0.20 per share represents an interesting capital allocation decision. With $15.1M of the $20.2M Tax Act liability already paid and improving operational cash flows, the dividend appears sustainable in the near term, though it bears watching given the operating losses.

The relocation of corporate headquarters from Hong Kong to California could impact operational costs and administrative efficiency, potentially affecting future margins. This move, combined with the company's focus on the Hong Kong market's growth, suggests a strategic rebalancing of operational and market priorities.

Net sales from our most important Hong Kong business up sequentially and year-over-year during the 4th quarter
– Positive cash flows from operations before 2017 Tax Act installment for the 4th quarter as well as the full year of 2024
– Declared a quarterly cash dividend of $0.20 per share

LOS ANGELES, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2024.

Fourth Quarter 2024 Financial Highlights

  • Revenue of $10.8 million was roughly unchanged compared to $10.9 million in the fourth quarter of 2023. Revenue from our Hong Kong business increased 9% sequentially and 7% compared to the fourth quarter of 2023.
  • Operating loss was $421,000, compared to $292,000 in the fourth quarter of 2023. The increase primarily can be attributed to the timing of expenses incurred year-over-year.
  • Net income was $176,000, or $0.02 per diluted share, compared to $358,000, or $0.03 per diluted share, in the fourth quarter of 2023.
  • The number of Active Members1 were 30,870 at December 31, 2024, roughly unchanged compared to 30,880 at September 30, 2024, and decreased 5% compared to 32,410 at December 31, 2023.
1Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.
  

Full Year 2024 Financial Highlights

  • Revenue of $43.0 million decreased 2% compared to $43.9 million in 2023.
  • Operating loss was $1.3 million, compared to $1.7 million in 2023.
  • Net income was $572,000, or $0.05 per diluted share, compared to $568,000, or $0.05 per diluted share, in 2023.

Management Commentary

"Our fourth quarter performance was steady as our business in Greater China achieved a 7% increase in net sales compared to the fourth quarter of 2023 and a 9% increase compared to last quarter, despite ongoing tepid consumer sentiment. Overall, our results for the fourth quarter and the full year were tempered by the performance of other markets, particularly Taiwan and North America, where we implemented strategic price adjustments in 2023 and offered fewer product promotions throughout 2024. However, these changes position us for long-term benefits of safeguarding margins and reinforcing market discipline."

Corporate Development

In February 2025, the Company relocated its corporate headquarters from Hong Kong back to Rolling Hills Estates, California.

Balance Sheet and Cash Flow

  • Net cash provided operating activities was $88,000 in the fourth quarter of 2024, compared net cash used in operating activities of $69,000 in the fourth quarter of 2023. Net cash used in operating activities was $3.4 million in 2024, compared to $4.3 million in 2023. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the “Act Act”), cash provided by operating activities was $602,000 in 2024, versus cash used in operations of $1.2 million a year ago. Of the total Tax Act liability of $20.2 million, $15.1 million has been paid to date.
  • Total cash, cash equivalents and marketable securities were $43.9 million as of December 31, 2024, down from $46.3 million as of September 30, 2024.
  • On February 3, 2025, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on February 28, 2025 to stockholders of record as of February 18, 2025.

The Company expects to issue its 2024 audited financial results in late February with its Annual Report on Form 10-K to be filed with the United States Securities and Exchange Commission. These financial results are preliminary and the accompanying financial statements have not been audited or have not yet been reviewed by the Company’s independent accountants. Significant updates and revisions may be required before the release of the Company’s 2024 audited financial results.

Fourth Quarter and Full Year 2024 Financial Results Conference Call

Management will host a conference call to discuss the fourth quarter and full year 2024 financial results today, Wednesday, February 5, 2025 at 11:30 a.m. Eastern Time. The conference call details are as follows:

Date:Wednesday, February 5, 2025
Time:11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:1-877-407-0789 (Domestic)
1-201-689-8562 (International)
Conference ID:13750282
Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1698806&tp_key=ccfcb08f42
  

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on February 5, 2025 through 11:59 p.m. Eastern Time on February 12, 2025 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number:  13750282.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 28, 2024 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

   
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
   
 December 31, 
 2024  2023 
 (Unaudited)  
ASSETS       
Current assets:       
Cash and cash equivalents$13,533  $56,178 
Marketable securities 30,407    
Inventories 3,272   4,293 
Other current assets 3,771   3,758 
Total current assets 50,983   64,229 
Property and equipment, net 190   266 
Operating lease right-of-use assets 2,498   3,319 
Restricted cash 34   39 
Deferred tax asset 382   369 
Other assets 1,272   869 
Total assets$55,359  $69,091 
LIABILITIES AND STOCKHOLDERS’ EQUITY       
Current liabilities:       
Accounts payable$895  $990 
Income taxes payable 4,908   3,716 
Accrued commissions 2,021   2,067 
Other accrued expenses 1,425   1,170 
Deferred revenue 6,428   6,166 
Amounts held in eWallets 3,286   3,945 
Operating lease liabilities 1,127   1,146 
Other current liabilities 709   784 
Total current liabilities 20,799   19,984 
Income taxes payable    5,054 
Deferred tax liability 174   135 
Operating lease liabilities 1,514   2,318 
Total liabilities 22,487   27,491 
Stockholders’ equity:       
Preferred stock     
Common stock 13   13 
Additional paid-in capital 84,901   84,695 
Accumulated deficit (26,344)  (17,703)
Accumulated other comprehensive loss (1,301)  (1,069)
Treasury stock, at cost (24,397)  (24,336)
Total stockholders’ equity 32,872   41,600 
Total liabilities and stockholders’ equity$55,359  $69,091 
        
        



      
NATURAL HEALTH TRENDS CORP. 
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
      
 Three Months Ended December 31,  Year Ended December 31, 
 2024  2023  2024  2023 
 (Unaudited)  (Unaudited)     
Net sales$10,846  $10,937  $42,963  $43,924 
Cost of sales 2,802   2,789   11,178   11,175 
Gross profit 8,044   8,148   31,785   32,749 
Operating expenses:               
Commissions expense 4,549   4,553   17,571   18,414 
Selling, general and administrative expenses 3,916   3,837   15,513   16,006 
Total operating expenses 8,465   8,390   33,084   34,420 
Loss from operations (421)  (242)  (1,299)  (1,671)
Other income, net 396   708   1,919   2,416 
Income (loss) before income taxes (25)  466   620   745 
Income tax provision (benefit) (201)  108   48   177 
Net income$176  $358  $572  $568 
Net income per common share:               
Basic$0.02  $0.03  $0.05  $0.05 
Diluted$0.02  $0.03  $0.05  $0.05 
Weighted-average number of common shares outstanding:               
Basic 11,478   11,448   11,467   11,436 
Diluted 11,486   11,461   11,490   11,456 
                
                



   
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
   
 Year Ended December 31, 
 2024  2023 
CASH FLOWS FROM OPERATING ACTIVITIES: (Unaudited)     
Net income$572  $568 
Adjustments to reconcile net income to net cash used in operating activities:       
Depreciation and amortization 131   164 
Net accretion of marketable securities (441)   
Share-based compensation 145   161 
Noncash lease expense 1,087   1,109 
Deferred income taxes 17   (178)
Changes in assets and liabilities:       
Inventories 1,000   228 
Other current assets (113)  (452)
Other assets (421)  (270)
Accounts payable (94)  181 
Income taxes payable (3,862)  (3,299)
Accrued commissions (19)  (866)
Other accrued expenses 271   (4)
Deferred revenue 245   565 
Amounts held in eWallets (672)  (947)
Operating lease liabilities (1,151)  (1,119)
Other current liabilities (62)  (119)
Net cash used in operating activities (3,367)  (4,278)
CASH FLOWS FROM INVESTING ACTIVITIES:       
Purchases of property and equipment (57)  (46)
Purchases of marketable securities (70,431)   
Proceeds from maturities of marketable securities 40,413    
Net cash used in investing activities (30,075)  (46)
CASH FLOWS FROM FINANCING ACTIVITIES:       
Dividends paid (9,213)  (9,215)
Net cash used in financing activities (9,213)  (9,215)
Effect of exchange rates on cash, cash equivalents and restricted cash 5   10 
Net decrease in cash, cash equivalents and restricted cash (42,650)  (13,529)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 56,217   69,746 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period$13,567  $56,217 
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:       
Right-of-use assets obtained in exchange for operating lease liabilities$124  $147 
        
        

CONTACT:

Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com


FAQ

What was NHTC's revenue performance in Q4 2024?

NHTC's Q4 2024 revenue was $10.8 million, relatively unchanged from $10.9 million in Q4 2023.

How did NHTC's Hong Kong business perform in Q4 2024?

NHTC's Hong Kong business showed strong growth with a 9% sequential increase and 7% year-over-year growth in Q4 2024.

What was NHTC's net income per share for full-year 2024?

NHTC reported net income of $0.05 per diluted share for full-year 2024.

How much is NHTC's quarterly dividend for Q4 2024?

NHTC declared a quarterly cash dividend of $0.20 per share, payable on February 28, 2025.

What was NHTC's cash position at the end of 2024?

NHTC had total cash, cash equivalents and marketable securities of $43.9 million as of December 31, 2024.

Natural Health Trends Corp

NASDAQ:NHTC

NHTC Rankings

NHTC Latest News

NHTC Stock Data

53.65M
7.47M
35.1%
10.29%
0.23%
Internet Retail
Wholesale-miscellaneous Nondurable Goods
Link
Hong Kong
ROLLING HILLS ESTATES